Uncategorized

Pulmonary fibrosis biotech Avalyn Pharma files for IPO

Published

on

A biotech developing inhaled formulations of approved pulmonary fibrosis pills wants to tap the public markets to fund its late-stage work.

Avalyn Pharma submitted its pitch on Wednesday night for a …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version